Medpace Holdings (MEDP) Tops Q2 EPS by 8c, Beats on Revenues; Offers FY17 EPS Guidance Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. SPY
5. FDX
6. IBM
7. MU
8. PFE
9. AWK
10. ACN

Go back to Medpace Holdings (MEDP) Tops Q2 EPS by 8c, Beats on Revenues; Offers FY17 EPS Guidance Above Consensus

Medpace (MEDP) PT Raised to $31 at Jefferies; Remains Sidelined

August 2, 2017 8:59 AM EDT

Jefferies raised its price target on Medpace (NASDAQ: MEDP) to $31.00 (from $30.00) while maintaining a Hold rating. Bad debt was reduced/avoided, and bookings improved sequentially. EBITDA guidance post 1Q17 ($106-108M) included $2-3M of bad debt exposure expected to hit the... More